These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3044982)

  • 1. Influence of tuftsin-like synthetic peptides derived from C-reactive protein (CRP) on platelet behaviour.
    Fiedel BA
    Immunology; 1988 Jul; 64(3):487-93. PubMed ID: 3044982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of C-reactive protein on platelet function. II. Inhibition by CRP of platelet reactivities stimulated by poly-L-lysine, ADP, epinephrine, and collagen.
    Fiedel BA; Gewurz H
    J Immunol; 1976 Oct; 117(4):1073-8. PubMed ID: 977942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Generation of thromboxane A2 and aorta-contracting activity from platelets stimulated with modified C-reactive protein.
    Simpson RM; Prancan A; Izzi JM; Fiedel BA
    Immunology; 1982 Sep; 47(1):193-202. PubMed ID: 7118160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective inhibition of platelet activation by the amyloid P-component of serum.
    Fiedel BA; Ku CS; Izzi JM; Gewurz H
    J Immunol; 1983 Sep; 131(3):1416-9. PubMed ID: 6886420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Stimulation of oxygen metabolism in human blood phagocytes as affected by tuftsin-like peptides derived from the C-reactive protein molecule].
    Polevshchikov AV; Nazarov PG
    Biull Eksp Biol Med; 1993 Jan; 115(1):55-6. PubMed ID: 8054580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Tuftsin-like peptides from a C-reactive protein molecule as regulators of lymphocyte proliferation].
    Polevshchikov AV; Nazarov PG
    Vopr Med Khim; 1994; 40(1):4-7. PubMed ID: 8122411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cleaved forms of C-reactive protein are associated with platelet inhibition.
    Fiedel BA; Gewurz H
    J Immunol; 1986 Apr; 136(7):2551-5. PubMed ID: 2419439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of C-reactive protein on platelet function. I. Inhibition of platelet aggregation and release reactions.
    Fiedel BA; Gewurz H
    J Immunol; 1976 May; 116(5):1289-94. PubMed ID: 58027
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A cell attachment peptide from human C-reactive protein.
    Fernandez MC; Mullenix MC; Christner RB; Mortensen RF
    J Cell Biochem; 1992 Sep; 50(1):83-92. PubMed ID: 1429876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of C-reactive protein on platelet function. III. The role of cAMP, contractile elements, and prostaglandin metabolism in CRP-induced inhibition of platelet aggregation and secretion.
    Fiedel BA; Simpson RM; Gewurz H
    J Immunol; 1977 Sep; 119(3):877-82. PubMed ID: 70475
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmentation of 1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine (PAF)-induced human platelet activation by C-reactive protein.
    Kohayakawa M; Inoue K
    Thromb Res; 1986 Mar; 41(5):649-57. PubMed ID: 3083530
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet inhibitory effects of CRP preparations are due to a co-isolating low molecular weight factor.
    Fiedel BA; Potempa LA; Frenzke ME; Simpson RM; Gewurz H
    Immunology; 1982 Jan; 45(1):15-22. PubMed ID: 7056562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity.
    Robey FA; Ohura K; Futaki S; Fujii N; Yajima H; Goldman N; Jones KD; Wahl S
    J Biol Chem; 1987 May; 262(15):7053-7. PubMed ID: 3034878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of platelets by modified C-reactive protein.
    Fiedel BA; Simpson RM; Gewurz H
    Immunology; 1982 Mar; 45(3):439-47. PubMed ID: 7061105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modulation of stimulus-dependent human platelet activation by C-reactive protein modified with active oxygen species.
    Miyazawa K; Kiyono S; Inoue K
    J Immunol; 1988 Jul; 141(2):570-4. PubMed ID: 3385211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hemorrhagin catrocollastatin inhibits collagen-induced platelet aggregation by binding to collagen via its disintegrin-like domain.
    Zhou Q; Dangelmaier C; Smith JB
    Biochem Biophys Res Commun; 1996 Feb; 219(3):720-6. PubMed ID: 8645248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelet activation, oxidative stress and overexpression of inducible nitric oxide synthase in moderate heart failure.
    de Meirelles LR; Resende Ade C; Matsuura C; Salgado A; Pereira NR; Cascarelli PG; Mendes-Ribeiro AC; Brunini TM
    Clin Exp Pharmacol Physiol; 2011 Oct; 38(10):705-10. PubMed ID: 21806669
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peptides generated from C-reactive protein by a neutrophil membrane protease. Amino acid sequence and effects of peptides on neutrophil oxidative metabolism and chemotaxis.
    Shephard EG; Anderson R; Rosen O; Myer MS; Fridkin M; Strachan AF; De Beer FC
    J Immunol; 1990 Sep; 145(5):1469-76. PubMed ID: 2166760
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the enzymatic sensitivities of the platelet receptor for human C-reactive protein and its functional relationship to the platelet IgG Fc receptor.
    Fiedel BA; Siegel JN; Gewurz H; Simpson RM; Izzi JM
    Clin Exp Immunol; 1982 Oct; 50(1):215-22. PubMed ID: 7172507
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.